ATLANTA, July 30, 2019 /PRNewswire/ — Second Quarter and Recent Business Highlights: Total revenues were $71.1 million in the second quarter of 2019, reflecting year over year growth of 4% and a 7% increase on a non-GAAP constant currency basis, both compared to the second quarter of 2018 BioGlue® revenues increased 5%, and 7% on […]
Other News
Reflow Medical Enrolls First Patients in DEEPER OUS Spur Stent Trial
San Clemente, Calif., July 30th, 2019–(BUSINESS WIRE) —Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a 100-patient prospective, non-randomized, multicenter trial designed to assess the safety and efficacy of the Temporary Spur Stent […]
SentreHEART Announces Initial Clinical Use of the LARIAT® with EpiRAIL™ Procedure for Left Atrial Appendage Exclusion
REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., announced it has successfully completed nine First-In-Human procedures utilizing the LARIAT® with EpiRAIL™ at John Paul II hospital in Krakow, Poland. The LARIAT with EpiRAIL is an epicardial-only, percutaneous approach to complete and permanent closure of the left atrial appendage (LAA) in patients with atrial fibrillation […]
Reflow Medical Enrolls First Patients in DEEPER OUS Spur Stent Trial
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a 100-patient prospective, non-randomized, multicenter trial designed to assess the safety and efficacy of the Temporary Spur Stent System compared to […]
Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
BEDMINSTER, N.J., and DUBLIN, Ireland, July 29, 2019 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that, in connection with its previously announced underwritten public offering of American Depositary Shares (“ADSs”), the underwriters of the offering have exercised in full their option to purchase up to an aggregate of […]
Silk Road Medical Reports Second Quarter 2019 Financial Results and Raises 2019 Outlook
SUNNYVALE, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended June 30, 2019. Recent Highlights Revenue of $14.9 million for the second quarter of […]
Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that physicians in four U.S. sites have successfully treated several patients with […]
Magenta Medical Closes Funding Round Led by NEA in Its First-Ever Life Sciences Investment in Israel
KADIMA, Israel, July 29, 2019 /PRNewswire/ — Magenta Medical, the developer of heart failure solutions based on proprietary miniaturized blood pump technology, today announced a financing round led by global venture capital firm New Enterprise Associates (NEA), with participation from existing investors, including Pitango Venture Capital, JVC Investment Partners and a group of private […]
Northeast Ohio Man Survives Extreme Cardiac Event, Receives 30+ Defibrillations
News Release Department of Marketing and Communications 11100 Euclid Avenue Cleveland, OH 44106 Northeast Ohio Man Survives Extreme Cardiac Event, Receives 30+ Defibrillations UH Geauga Medical Center team shows perseverance and expertise in incredible effort A Northeast Ohio man who experienced what likely would have been a deadly […]
Cardiovascular Systems, Inc. Announces Former U.S. Congressman Erik Paulsen Joins Board of Directors
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Erik Paulsen. He replaces director Scott Bartos, who is retiring from the board after […]



